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Abstract 
 
Objective To explore how bereaved family members recall managing end of life medications 
when delivering care to a patient dying at home in England. 
 
Design Qualitative study. 
 
Setting  Domestic homes in two contrasting areas in England. 
 
Participants 59 bereaved family carers who have delivered care to a patient who spent a 
minimum of   two weeks at home prior to their death from cancer or other non-malignant 
condition. Cases were excluded if place of death was: hospice, nursing home or NHS 
hospital. 
 
Results  Participants identified a number of important concerns about managing end of life 
medication for the dying person at home. Although some support with medications is 
provided by general practitioners and nurses in the community, family carers take primary 
responsibility for drug administration and storage. They reported anxiety about giving correct 
and timely dosages, and concerns about keeping the patient comfortable without overdosing 
them or risking shortening their lives. In particular they reported that certain analgesic 
medications, especially opioids, were considered to have a symbolic significance and 
increasing analgesia and the use of a syringe driver were associated with deterioration and 
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approaching death.  Key barriers to managing end of life medications at home included: 
complex regimes; unwanted responsibility in deciding when to use ‘as needed’ medication; 
disagreements with professional staff and anxiety about medication errors, especially if 
perceived to have implications for survival. 
 
Conclusions Family carers require more information about end of life drugs and their effects, 
support and training in managing medication for a dying person.  Significant concerns were 
identified, and these need to be addressed if current UK policy to increase the number of 
patients dying at home is to be safely realised.   
 
Words: 276  
Key words: palliative care, end of life care, terminal care, medication adherence, general 
practitioners, community health nursing, caregivers, qualitative research  
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INTRODUCTION 
In the context of limited health-care resources, and evidence of patient preferences for dying 
at home, the role of family carers (family, friends and significant others; hereafter called 
‘family carers’) in delivering end of life care at home is increasingly important.  Hospital care 
in the last year of life is known to account for a considerable proportion of health care 
expenditure in the United Kingdom1 and the United States2.  Evidence from a review of cost 
and cost-effectiveness indicates that all types of palliative care, but especially home-based 
care, are frequently found to be less costly compared to other options3. There is strong 
evidence from a systematic review that home-based palliative care reduces symptom burden 
for patients while not increasing family carers’ grief during bereavement4.  However, the 
presence of family carers able and willing to provide care in the home is a key determinant of 
outcomes for cancer patients5. 
 
The End of Life Care Strategy6 for adults in England aims to improve the accessibility of high 
quality care for all people who are approaching the end of life.  According to the Strategy, 
which describes family carers as ‘co-workers’ with the health and social care team, patients 
should be provided with more choice over where they receive end of life care.  Evidence 
suggests that two-thirds of patients would prefer to die at home, with current trends 
suggesting a modest increase over the last decade in home deaths to 21% in 20107.  Policy 
initiatives have emphasised primary health care and have highlighted the important role of 
the general practitioner in co-ordinating and managing end of life care6.   For example, there 
has been a widespread introduction of ‘anticipatory prescribing’ in community based 
palliative care across the UK, whereby GPs prepare prescriptions for patients identified to be 
nearing the end of life8. This ensures essential drugs are available within the home ‘out of 
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hours’ to enable rapid symptom management and prevent unnecessary hospital admission.  
They are usually called ‘just in case’ medications, and comprise four core drugs including 
strong opioids and sedatives, although the drugs actually prescribed may vary across the 
country. Within the home context, community nurses are often involved in decisions about 
the actual initiation, dosage and delivery of these medications, which some nurses report as 
problematic9.  Survey data from bereaved carers indicate that pain management is less good 
than in other care settings (insert reference to end of life survey). 
Family carers play a crucial role in supporting those who wish to die at home. Of the 6.5 
million people in the UK fulfilling an unpaid caring role for a family member, approximately 
half a million do so within the context of an end of life phase, and the majority of them will 
be female aged 50-64 years while  in older groups slightly more men provide care10.  It is 
widely recognised that they provide physical care, emotional and social support, financial 
resources, advocacy and anticipatory care, and assist patients’ in negotiating and co-
ordinating care during the final period of life11,12.  It is a challenging and demanding role, 
which few people aspire to, but which may be thrust upon them, in often difficult 
circumstances and following a ‘crisis’.  Undertaking this role may have physical, 
psychological, social and financial consequences for carers which outlast their period of care 
and may influence their bereavement.  Despite focused policy initiatives13,14 to address these 
caring demands, a large study in England on transitions between places of care in end of life 
care, reported that in 2013 little has changed to improve family carers’ experiences15. Until 
relatively recently, there has been little research about how family carers manage their role in 
caring for those who are approaching death16,17.    
It is family carers, rather than GPs or community nurses, who often have to manage the safe 
storage and delivery of end of life medications in the home on a day-to-day basis, and arrange 
for their disposal following the death. Evidence from a small study of 23 family carers of 
6 
 
patients in a home hospice programme in the USA, identified five conceptual factors that 
influenced medication management, however, major differences in healthcare systems limits 
its applicability in the UK (insert Lau et al references). A survey of 98 multidisciplinary US 
home-hospice staff indicated that 67% rated medication management as the most important 
role of family carers, but only 6% routinely offered education, support and counselling to 
facilitate this18.  Little is known about  the complex realities of managing end of life 
medications at home  in the UK from the perspective of family carers.  Therefore, we elicited  
in-depth interview accounts from  bereaved family carers of their experiences of end of life 
medication19.  The study is part of a larger project exploring the issues faced by family 
members caring for a dying older person at home, and the way the home is transformed in the 
process of providing end of life care. Details of the full study are published20. 
 
 
METHODS 
Design 
We utilised a cross-sectional qualitative research design.     
Setting 
The study was conducted in two areas: the North West (NW) (Lancashire and Cumbria) and South 
West (SW) (East Devon) of England. These regions were selected because they both have high 
proportions of older people in the population21. Census data and informal discussions with 
professionals and stakeholders indicated some differences between the two areas in terms of 
socioeconomic status, types of home ownership, ethnic and cultural diversity and health indices 
(such as smoking rates), which the research team believed would add diversity to the data collected.  
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Sampling 
We used purposive sampling of bereaved family carers to select those with direct experience 
of providing care for an older person dying at home.   The inclusion criteria included: family 
carers of older deceased people (aged 50 years +) from any cause of anticipated death; death 
occurring in the home of the carer or patient; a minimum of two weeks  care in the private 
home prior to death; adult carer (>18 years); and recruited at least 6 months but not more than 
24 months following the death. The exclusion criteria included: carers who were cognitively 
impaired, unable or unwilling to give consent. Initially inclusion was limited to the first 13 
months of bereavement but subsequently extended to 24 months to increase the sample.  
Recruitment 
Family carers were recruited through GP practices. Researchers (MT and SB) arranged 
meetings with GPs or other staff (e.g. research nurses or practice managers) in each 
participating practice, to discuss the study. Practice staff then searched practice databases to 
identify family carers who met all the study criteria, and information packs were posted to 
potential participants who responded directly to the research team if they wished to be 
involved.   
Data collection 
MT and SB conducted single face-to-face interviews of 15 – 102 minutes (mean = 47 
minutes) in participants’ homes from December 2011 to August 2012. Participants had been 
bereaved a median of 12 months (range 7-22 months). The interview guide was developed 
following a review of the literature and relevant policy, and sought to address the study aims.  
It was designed to elicit chronological narratives of care provision during the dying process, 
death and early period of bereavement using open ended questions and follow up prompts 
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(see Figure 1 ). The interview was pilot tested with three bereaved carers and modified to 
include further questions about medication management.  In this paper, we report on 
perspectives from family carers on end of life medication at home.   
 
Analysis 
Interviews were digitally recorded with participants’ permission, then fully transcribed.  All 
interview transcripts were ‘cleaned’ by MT and checked against the audio recordings for 
accuracy to eliminate errors, and to remove any identifiers to preserve anonymity.  To ensure 
reliability, two transcripts were independently read, initial codes identified, then two more 
transcripts were again independently coded to check the initial framework and were agreed 
by all team members. Based on this, a final coding framework was refined and compared to 
subsequent selected transcripts within the team.  This final coding framework was applied to 
all transcripts using the data analysis software NVivo, with any discrepancies discussed.  The 
principles of a constant comparative approach to analysis were utilised, in that codes were 
derived from the data rather than developed a priori22.  An iterative approach to coding of 
themes was taken until saturation of themes was achieved23.  These were presented at two 
deliberative workshops held in Lancaster and London of 33 people comprising members of 
our expert advisory group, practitioners and service users.  Feedback from these events was 
incorporated into the final analysis presented here.  Direct quotations have been selected to 
highlight typical responses, and are indicative of the diversity of views elicited. To establish 
rigor, we adhered to COREQ guidelines24.  
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RESULTS 
We interviewed 59 bereaved family carers (response rate 54%) who have delivered care to a 
patient who spent at least two weeks at home prior to their death from cancer or other non-
malignant condition (see Table 1). In the SW, 52 invitations were sent out, and 38 people 
responded (73% response rate) but two subsequently declined to take part in an interview. 
The pattern of recruitment was markedly different in the NW, where 76 invitations were sent 
out, and 31 people responded (41% response rate). Of these, six subsequently declined, one 
did not meet the study’s inclusion criteria and one agreed to participate but then withdrew.  
The majority of carers (69%) were female, and the majority of deceased patients were male 
(59%), reflecting the fact that 73% were spouses. Three quarters of the people they cared for 
died from cancer.  The median length of time that they had provided care at home was 11 
months (range 2 weeks – 11 years).  
Following an extensive analysis, we have selected two main themes to present in this paper. 
Decision-making processes in managing end of life medication at home 
Managing complex medications 
All 59 participants interviewed reported that they were involved in some aspects of managing 
or assisting with end of life medications, especially once the patient became  dependent and 
was in the final phase of dying.  The degree to which they regarded this as burdensome was 
on a continuum from not at all, to greatly.  The complexity of medication management was 
reported as problematic for those with chronic conditions where polypharmacy was 
highlighted .   
‘He’d been on quite a lot of tablets for some time, you know, blood pressure, heart tablets, 
warfarin and one or two other things’ [A01 SW Female 78] 
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A number of strategies to facilitate medication management such as timely and accurate 
dosages were described:  
‘I made a copy of all the tablets and the different times he was to have them and which ones 
[...] I made a chart on the computer and just printed it out each time, and that was very 
helpful.’ [A11 SW Female 60] 
 
Taking responsibility 
There appeared to be a shift in responsibility for medication management from self-care to 
the family member taking control as dependency increased.  Some participants reported the 
responsibility as demanding because they feared the consequences of making a mistake or 
because they did not fully understand the medication regimes, especially in the context of 
their own distress, which made decision-making or assimilating new information difficult .  
‘It’s a very big responsibility and in a way I felt helpless because I felt that some things 
needed increasing and the nurses weren’t there to do it, but at the same time I don’t think it 
would have been right for me to have total control over it because my head was all over the 
place at times. [B01 NW Female 77] 
 
 In addition, they highlighted that while the community nurses were, overall, helpful and 
supportive, they were not in the home all of the time, so variation to medication, especially 
for ‘as needed’ drugs, required them to make decisions unaided. One participant perceived 
that the occupational background of the patient (as an industrial pharmacist) had been an 
advantage.  Her account offers an empowered and proactive role in which both the patient 
and carer were confident in managing medications.  This experience was echoed in other 
examples where carers had previous qualifications in health professional disciplines. 
‘Now he was an industrial pharmacist, so when the medication came along right at the 
beginning, he told me what was what and he queried the doctor, how it would be. He always 
used to check that I was giving the tablets in the right way, but eventually of course he was 
unable to do that. But he had trained me well.’[B21 NW Female 80] 
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Disagreements with staff about medication  
One consequence for carers with health professional expertise is that some of them 
challenged the prescribed medication regimes.  .   
He had [the syringe driver] in for three days, and then when he was settled and I knew he was 
going to die I asked them to take it out. And the doctor didn’t think it was a good idea, but I 
said ‘I don’t want him dying with this thing in his arm, and I don’t want him having drugs...’ 
[...] I felt he needed to die a relatively natural death. [B19 NW Female 70] 
 
In this case, the preferences of the patient, according to the carer, to have a ‘natural death’ 
seems to have been continued in the final days of life, with the participant requesting the 
removal of the syringe driver used to deliver end of life drugs.  However, this was an atypical 
case; more often there was a desire for family carers to decrease the burden of their own 
decision-making, and a concern about explicitly challenging doctors’ and nurses’ care.  One 
participant viewed the process of requesting increased medication for symptom control from 
nurses as offering the potential for being misconstrued to be hastening death.  Overall, overt 
disagreements with staff were rarely reported in the interviews. 
‘I sometimes think [the nursing staff] need to listen to what the carer is saying; I think they 
did mostly but generally when I said she needs more sedation and they said ‘well she’s on 
such and such a dose’, which apparently was quite a big dose but it still wasn’t enough for 
her. And at one point I thought ‘God, do they think I’m trying to bump her off?’ which is 
another reason why I wouldn’t have liked the responsibility of the drugs.’ [B02 NW Female 
57] 
 
Managing end of life medications at home: concerns and rewards 
Carers’ anxiety about medications 
There was also the view that managing end of life medications at home was anxiety 
provoking.  There was recognition that these medications were necessary to provide symptom 
relief.  Some of the most frequently cited concerns were related to getting the dosage wrong, 
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especially concerns about overdosing patients, or in failing to administer the drugs when the 
patient become too ill to use the oral route. 
‘I was really anxious just to follow the instructions and I wrote everything down carefully 
that I had given her. I didn’t attempt to give her an overdose if that’s what you mean, I 
wouldn’t have known which one would have done it. ‘[B14 NW Male 72] 
 
Perceptions about the effects of morphine  
Underlying the anxieties about medication management was a specific concern and an 
apparent reluctance to use morphine or its equivalents (hereafter referred to as morphine).  
The accounts from participants in some cases attributed the reluctance to patients but there 
also seemed to be some need for participants to explain and justify the use of morphine, in the 
context of persuasion from nursing staff rather than any weakness or lack of moral courage 
by patients .    
              ‘When he was totally compos mentis he was doing it all himself, he used to say ‘these bloody 
tablets, you know they better do something’. But then when he became more sleepy then I 
was doing cos he was on liquid morphine then.’ [A08 SW Female 66] 
One participant expressed a dilemma in whether to administer morphine, although elected to 
give it despite her discomfort .  
‘[I gave him Oramorph] when he asked for it, I didn’t like to give him all... just when I 
thought he needed it, which was probably every day. At first I thought ‘Oh shall I use it or 
not?’ [B15 NW Female 63] 
 
While all participants were open to the use of morphine for pain relief, there were many 
descriptions of the adverse effects of this drug, especially on the mental state of the patient.  
Some perceived morphine to reduce the awareness of the patient, which was variously 
described as ‘a bit removed’, less ‘lucid’, ‘more and more distant’ or ‘very confused’ .  A 
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participant attributed an increase in agitation and disinhibition to morphine usage which 
poignantly robbed the dying person of dignity and left lasting distressing memories .  
‘I had my arms around him and he was talking to me normal whereas before he’d said some 
really horrible things, that’s the morphine.’ [A03 SW Female 76] 
 
 Another  participant opined that the amount of medication resulted in making basic care 
provision even more difficult as the patient was unable to communicate his needs effectively .   
‘And his speech started to go but we realised that he was so drugged we had awful trouble 
trying to find out whether he wanted something to drink, something to eat, to go to the loo, 
and I think he found it so frustrating cos he was an incredibly articulate person, so it was very 
hard.’ [A04 SW Female 67]  
 
There were suggestions that the complexity of managing morphine and its side effects such as 
nausea, further complicated other types of medication and disease management. 
 
Symbolic significance of syringe driver 
There was a perception that a change in route of medication administration to the 
subcutaneous route via a syringe driver signalled a transition to a dying status.  Two 
participants identified that the timing of starting a syringe driver was indicative of 
approaching end of life , although in not all cases was effective symptom management 
achieved . 
‘On the Monday they came and put a syringe driver in, so you knew then that it wouldn’t be 
long.’ [A19 SW Female 69]  
 
Rewards in managing end of life medications at home 
Participants also reported that there were positive experiences in caring for a person dying at 
home.  A critical first step in this process was feeling confident and competent  to manage 
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medication delivery either by drawing upon prior healthcare training or general caregiving 
knowledge .  
So it was okay… I think for the last few days I was giving her things like that [morphine].’ 
[B20 NW Male 82] 
 
One participant highlighted her feelings of satisfaction in the final hours of life, when having 
insisted on the withdrawal of all medication, she recalled a few precious moments when she 
communicated with her lucid husband, creating valued last memories . 
‘When all the medications ceased, he did become quite rational for about… oh… an hour. He 
was quite back to his old self and I sat with him and we talked (chuckles). And it was so 
lovely because he hadn’t known me. And just in that hour he did. And then he drifted off and 
he wasn’t really conscious anymore after that. [B13 NW Female 83] 
 
 
DISCUSSION  
This qualitative study examines, family carers’ accounts of the challenges of managing end of 
life care medications for a person dying at home.  Our study adds to the existing literature 
which has predominantly presented evidence from the professional perspectives of GPs25, 
community nurses10 or home-hospice providers19.  Current policy recommendations stress the 
need to facilitate more people dying at home6. The family carers sampled indicated that they 
had a major role in providing care and ensuring symptom management by careful medication 
delivery.  It is not surprising that it was perceived to be both a demanding responsibility and 
at times for some, anxiety provoking, given that they reported little information or education 
to facilitate their role. Our data indicate particular concerns about how end of life drugs, 
especially morphine, were perceived and experienced by family carers, and that the setting-up 
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of a syringe driver was seen to have a symbolic function as marking a transition into the final 
dying phase. 
 
 
Strengths and weaknesses of the study 
The diversity  of the findings are increased by purposively sampling across two areas of 
England. Further discussion  of the  analysis with  key stakeholders, practitioners and service 
users (patients and carers)  confirmed them as  resonant with their clinical or practical 
experiences.  We did not use respondent validation because of ethical concerns to minimise 
distress in our bereaved participants.  In comparison to previous research which has focused 
only on cancer patients cared for at home26, those with other chronic conditions were 
included. A potential limitation of our research design was the use of cross-sectional, 
retrospective accounts where the experience of bereavement may have influenced the self-
reports provided, especially for those later in the bereavement trajectory.  Future research 
should use serial interviews conducted throughout the caregiving trajectory. Caution is also 
required in interpreting the findings as we collected no data from GPs, community nurses or 
patients. As befitting a qualitative study, our intention has been to illuminate the experiences 
of family carers and provide clinically useful insights, rather than to make claims of 
population level generalizability.  
 
Strengths and weakness in relation to other studies, discussing important differences in 
results 
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The participants identified several barriers to managing end of life medications at home, 
largely due to their inexperience compounded by an apparent lack of knowledge or access to 
information. This is consistent with previous research done in the context of US hospice-
home care which highlighted the lack of specific medication management strategies such as 
education, support or counselling offered to family carers by the multidisciplinary team19 (add 
other references).  This is a paradox, in that health professionals, especially nurses, require 
extensive training and are regulated by procedures to ensure medication safety but there was 
little evidence from this study that similar attention is directed towards supporting family 
carers.  These difficulties are not unique to end of life medication management.  There is 
evidence that external cognitive support and education promote adherence to medication in 
older people27.  This lends support to the strategies initiated by family carers in our sample.  
A key finding was the degree of anxiety reported by family carers and the perception of 
responsibility and its burdensomeness in managing these medications.  In some cases, they 
appear to have to make critical decisions about delivering ‘as needed’ drugs or in altering 
dosages to achieve symptom relief, without, at times, support from primary care 
professionals.  Most carers’ accounts indicated that community nurses offered support either 
during home visits or over the telephone, but remarkably little reference was made to the 
involvement of GPs beyond the prescription of the drugs.  Our findings accord with those 
from a recent ethnographic study of decision-making by community nurses about the use of 
anticipatory end of life medication in two areas of England which demonstrates that initiation 
of the use of these types of drugs are largely at the discretion of nurses28.   Furthermore, our 
data indicated that family carers used the initiation of a syringe driver to deliver medication 
as a cue to the transition to dying. They also reported considerable concerns about the use of 
morphine, and what has been described elsewhere as opioidphobia29.  As has been observed 
in research on palliative sedation, there seemed to be a strong need for participants to explain 
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that they were not seeking to hasten death30.  Our study indicated that there were advantages 
for those with healthcare experience in that they reported a more proactive and equal 
relationship with the primary care team, and unsurprisingly had better access to information 
resources. 
 
Meaning of the study: possible explanations and implications for clinicians and 
policymakers 
In the context of the End of Life Care Strategy6, the findings from this study indicate that the 
family carers sampled did not believe themselves to have adequate support to safely deliver 
end of life medications to patients dying at home.  It raises questions about the way family 
carers are engaged as ‘co-workers’ as described in the Strategy.  Without adequate 
preparation, sufficient information/education and support in dealing with end of life 
medication, the implementation of current home-based end of life care policies seem destined 
to result in additional distress and burdensomeness for family carers.  A correlational study 
from Sweden indicates that feelings of preparedness for the role of caring was significantly 
associated with higher levels of hope, reward and with lower level of anxiety31. There may be 
opportunities to increase the role of community pharmacists to provide advice and training in 
the safe management, storage and disposal of medications.  Our study indicates that more 
effective communication is required from the primary care team about end of life 
medications.  Our evidence suggests that community nurses were most often mentioned as 
involved in medication delivery, and that generally they were found to be supportive10,28.   
The responsiveness and availability of home-based nurses and physicians is known to predict 
caregiver satisfaction32, however, for the majority of time, family carers have to manage 
alone. It is noteworthy that specific drugs, opioids, appeared to raise particular concerns for 
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family members and this possibly relates to residual aspects of the Shipman case, where a 
British GP was found guilty of serial murders of older patients using diamorphine.  We 
believe that open communication between GPs, community nurses and family carers 
regarding their roles and responsibilities during the use of end of life medications will help to 
prevent the anxieties reported.  The subgroup of family carers with healthcare knowledge 
appeared to establish more equitable relationships. 
 
Unanswered questions and future research 
Further in-depth research is needed on the roles and responsibilities of family carers 
regarding the use of end of life medications, especially anticipatory prescriptions.  We are 
aware that our method of constant comparative analysis does not permit detailed accounts of 
changes over time to be traced, therefore a narrative analysis paper is forthcoming.  Research 
on the views of dying patients on medication usage and how this is negotiated with their 
family members is warranted.  Likewise, research examining the effects of family carers’ 
education, age and information needs is required before appropriate interventions can be 
designed33.   
 
In conclusion, our study reveals how participants perceive end of life care medications as a 
core; but largely unrecognized and undervalued function of caring for a dying patient at 
home. Family carers require more information about end of life drugs, their effects, and 
support in managing these medications.  When formulating suggestions for end of life care 
policy at home, we suggest keeping in mind the central role of family carers. Significant 
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concerns were identified, and these need to be addressed if current UK policy to increase the 
number of patients dying at home is to be safely realised.   
 
 
 
 
 
 
  
20 
 
 
Acknowledgements 
 
The authors thank the bereaved family carers who participated.  We are grateful to the service users: 
Jill Robinson and Janet Ross-Mills and our International Advisory group members: John Ellershaw, 
Philip Larkin, Luc Deliens, James Goodwin, Heather Richardson and Jean Hardiman-Smith for their 
support. 
 
Contributors: SP conceived the study, CM, CT, SGB, MT, DS and XW made substantial 
contributions to its conception and design. MT and SB were responsible for sampling, data collection 
and MT for analysis. SP wrote the paper. All authors contributed to the analysis and interpretation of 
the data, and critically revising drafts of the paper. All authors read and approved the final version of 
the manuscript. SP is guarantor of the study. 
 
Funding: This research was supported by grant from Marie Curie Cancer Care but they had no role in 
data analysis or interpretation, nor in preparation, review or approval of the manuscript. 
 
Data sharing:  No additional data are available. 
 
Ethics approval: Ethics approval for this study was granted by NRES Committee North West – 
Lancaster, reference number 11/NW/0203 on 09/05/11 
 
Licence for Publication 
21 
 
The Corresponding Author has the right to grant on behalf of all authors and 
does grant on behalf of all authors, an exclusive licence (or non exclusive 
for government employees) on a worldwide basis to the BMJ Publishing Group Ltd 
to permit this article (if accepted) to be published in BMJ Supportive and 
Palliative Care and any other BMJPGL products and sublicences such use and 
exploit all subsidiary rights, as set out in our licence 
(http://group.bmj.com/products/journals/instructions-for-authors/licence-
forms). 
 
Competing Interest 
All authors have completed the Unified Competing Interest form at 
www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and 
declare that (1) SP, MT, DS, CM, CT, SB, XW, SB have support from Marie Curie Cancer 
Care for the submitted work; (2) SP, MT, DS, CM, CT, SB, XW, SB no relationships with 
Marie Curie Cancer Care that might have an interest in the submitted work in the previous 3 
years; (3) their spouses, partners, or children have no financial relationships that may be 
relevant to the submitted work; and (4) SP, MT, DS, CM, CT, SB, XW, SB have no non-
financial interests that may be relevant to the submitted work. 
 
References 
1. Hatziandreu E, Archontakis F, Daly A, et al National Audit Office. The potential cost 
savings of greater use of home- and hospice-based end of life care in England. 
Cambridge: RAND Corporation, 2008. 
2. Riley GF and Lubitz JD Long-term trends in Medicare payments in the last year of 
life. Health Serv Res 2010; 45: 565-576. 
3. Smith S, Brick A, O’Hara S, Normand C. Evidence on the cost and cost-effectiveness 
of palliative care: a literature review. Palliative Medicine Published online Jul 9, 2013 
DOI: 10.1177/0269216313493466 
4. Gomes B, Calanzani N, Curiale V, McCrone P and Higginson IJ Effectiveness and 
cost-effectiveness of home palliative care services for adults with advanced illness 
and their caregivers (review). The Cochrane Library,  2013, 6; 1-128. 
5. Gomes B, Higginson IJ. Factors influencing death at home in terminally ill patients 
with cancer: systematic review. BMJ 2006, 332: 515-521. 
22 
 
6. Department of Health: End of life care strategy: promoting high quality care for all 
adults at the end of life. London: Department of Health; 2008. 
7. Gomes B, Higginson IJ. Where people die (1974-2030): past trends, future projections 
and implications for care. Palliative Medicine 2008; 22(1): 33-41.  
8. Faull, C., Windridge, K., Ockleford, E. & Hudson, M. (2013) Anticipaory prescribing 
in terminal care at home: what challenges do community health professionals 
encounter? BMJ Supportive and Palliative Care, 3, 91-97. 
9. Wilson, E. & Seymour, J. (2013) Understanding the role of nurses in the management 
of symptoms and distress in the last days of life.  In S. Sterckx, R. Kasper and F. 
Mortier (eds.) Continuous Sedation at the End of Life. Cambridge: Cambridge 
University Press. 
10. NCPC: National Council for Palliative Care. (2012). Who Cares? Support for carers 
of people approach the end of life. London, The National Council for Palliative Care. 
11. Payne S. EAPC Task Force on Family Carers White Paper on improving support for 
family carers in palliative care: part 1. European Journal of Palliative Care 2010, 17 
(5): 238-245. 
12. Payne S. EAPC Task Force on Family Carers White Paper on improving support for 
family carers in palliative care: part 2. European Journal of Palliative Care 2010, 17 
(6): 286-290. 
13. DOH (2008). Carers at the heart of 21st-century families and communities: A caring 
system on your side. A life of your own. London, Department of Health. 
14. DOH (2010) Recognised, Valued and Supported: next steps for the carers strategy. 
Department of Health, London 
23 
 
15. Hanratty, B. Lowson E, Holmes L, Grande G, Arthur T, Addington-Hall J, Payne S, 
Seymour J (2013). Transitions at the end of life for older adults: Patient, carer and 
professional perspectives. Final Report to NIHR SDO. 
16. Grande G, Stajduhar K, Aoun S, Toye C, Funk L, Addington-Hall J, Payne S and 
Todd C. Supporting lay carers in end of life care: current gaps and future priorities. 
Palliat Med, 2009, 23 (4): 339-344 
17. Payne, S. and Grande G. ‘Towards better support for family carers: A richer 
understanding.’ Palliat Med 2013 27(7): 579-580. 
 
18. Joyce BT and Lau DT. Hospice experiences and approaches to support and assess 
family caregivers in managing medications for home hospice patients: a providers 
survey. Palliat Med 2013 27(4): 329-38 
 
19. Grande G Palliative care in hospice and hospital: time to put the spotlight on neglected 
areas of research. Palliat Med 2009; 23:187-9 
 
20. Payne S, Brearley S, Milligan C, Seamark D, Thomas C, Wang X, Blake S and 
Turner M. (2012) The perspectives of bereaved family carers on dying at home: the 
study protocol of ‘unpacking the home: family carers’ reflections on dying at home’. 
BMC Palliative Care 11:23; http://www.biomedcentral.com/1472-684X/11/23.  
21. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/6871/187
1208.pdf accessed 9 October 2013 
 
24 
 
22. Strauss A, Corbin JL: Basics of Qualitative Research: Techniques and Procedures for 
Developing Grounded Theory (2nd ed.) Thousand Oaks CA: Sage; 1998. 
 
23. Seale C: The Quality of Qualitative Research. London: Sage; 1999. 
 
24. Tong A, Sainsbury P and Craig J. (2007) Consolidated criteria for reporting 
qualitative research (COREQ): a 32-item checklist for interviews and focus groups. 
International Journal for Quality in Health Care 19 (6) 349-357 
 
25. Barclay, S., & Maher, J. (2010). Having the difficult conversations about the end of 
life. BMJ, 341, c4862. 
26. Thomas C, Morris S, Clark D. Place of death in the Morecambe Bay area: patterns 
and preferences for place of final care and death among terminally ill cancer patients. 
Social Science and Medicine 2003, 58: 2431. 
27. Higgins N, Regan C. A systematic review of the effectiveness of interventions to help 
older people adhere to medication regimes. Age and Ageing 2004; (33) 224-229. 
28. Wilson E, Seymour J. What factors do community nurses identify as important when 
administering medication prescribed in advance of end of life symptoms? A 
qualitative study in England. Journal of Pain and Symptom Management (submitted) 
29. World Health Organization. Ensuring balance in national policies on controlled 
substances. Guidance for availability and accessibility of controlled medicines. 
Geneva: World Health Organization; 2011. 
30. Seymour J, Rietjens J, Bruinsma S, Deliens L, Sterckx S, Mortier F, Brown J, 
Mathers N, van der Heide A Continuous sedation in end of life care for cancer 
25 
 
patients: a qualitative interview study of physicians’ and nurses’ practice in three 
European countries.  Journal of Clinical Oncology (in press) 
31. Henriksson A and Arestedt K Exploring factors and caregiver outcomes associated 
with feelings of preparedness for caregiving in family caregivers in palliative care: a 
correlational, cross-sectional study.  Palliative Medicine 2013, 27(7) 639-646. 
32. Guerriere DN, Zagorski B and Coyte PC. Family caregiver satisfaction with home-
based nursing and physician care over the palliative care trajectory: results from a 
longitudinal survey questionnaire. Palliative Medicine 2013, 27(7) 632-638. 
33. Grande GE, Farquhar MC, et al. Barclay SI, Todd CJ. The influence of patient and 
carer age in access to palliative care services. Age and Ageing 2006; 35: 267-73. 
 
  
26 
 
 
 
  
 
What is already known on this subject 
 
We know from previous work that family carers deliver the 
majority of physical, psychological, social and anticipatory care to 
a patient dying at home. 
 
We know from research with GPs, community nurses and 
hospice-home care that delivering end of life care medications at 
home, especially using ‘as needed’ anticipatory prescriptions, is 
beneficial in improving symptom management and preventing 
hospital admissions but is practically challenging. 
 
What this study adds 
 
This study uses comprehensive in-depth interviews to explore 
the accounts of bereaved family carers on decision-making and 
delivery of end of life medications to a patient dying at home. 
 
Our study suggests that, in two areas of England, bereaved 
family carers report insufficient information, education and 
support, and anxieties about the use of end of life medications.  
 
This indicates the need for better communication if current UK 
policy to increase the number of patients dying at home is to be 
safely realised.   
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Table 1 Characteristics of participants in interviews. 
 N = 59 % range median 
Location in England     
North West 23 39   
South West 36 61   
     
Gender of carer     
Male 18 31   
Female 41 69   
     
Age of carer     
All 59  44 – 90  72 
< 50 1 2   
50 – 59 7 12   
60 – 69 19 32   
70 – 79  15 25   
80 – 81 16 27   
> 90  1 2   
     
Ethnicity of carer     
White British 56 95   
White other 2 3   
Black Caribbean  1 2   
     
Relationship to deceased     
Spouse  43 73   
Daughter/son 15 25   
Sibling  1 2   
     
Gender of deceased      
Male  35 59   
Female 24 41   
     
Age of deceased     
All    59 – 98  82 
50 – 59  3 5   
60 – 69  8 14   
70 – 79  15 25   
80 – 89  23 39   
> 90  10 17   
     
Time cared for in the home   2wks – 11 
yrs  
11 months 
     
Cause of death     
Cancer 37 63   
COPD 1 2   
Heart disease 6 10   
Dementia  3 5   
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PD 3 5   
Old age 5 8   
Renal failure 1 2   
Other  3 5   
     
Occupation of carer     
Modern professional 17 29   
Clerical / intermediate 15 25   
Senior managers 3 5   
Technical / craft  2 3   
Semi-routine manual  7 12   
Routine manual  3 5   
Middle/junior managers 5 9   
Traditional professional  2 3   
No paid employment  5 9   
     
Occupation of deceased     
Modern professional 13 20   
Clerical / intermediate 7 12   
Senior managers 1 2   
Technical / craft  8 14   
Semi-routine manual  5 9   
Routine manual  6 10   
Middle/junior managers 8 14   
Traditional professional  5 9   
No paid employment  6 10   
     
 
